Article date: May 1999
By: Jean‐Paul Dumas, Françoise Goirand, Marc Bardou, Monique Dumas, Luc Rochette, Charles Advenier, Jean‐François Giudicelli, in Volume 127, Issue 2, pages 421-428
The aims of this study were to compare, in the rat isolated perfused lung preparation, the antagonist effects of a nonselective β‐adrenoceptor agonist (isoprenaline), a selective β2‐adrenoceptor agonist (salbutamol) and a selective β3‐adrenoceptor agonist (SR 59104A) on the hypoxic pulmonary pressure response, and to investigate the role of K+ channels, endothelium derived relaxing factor and prostaglandins in these effects. K+ channels were inhibited by glibenclamide, charybdotoxin or apamin, NO synthase and cyclo‐oxygenase were inhibited by NG‐nitro‐L‐arginine methyl ester (L‐NAME) and indomethacin, respectively.
Hypoxic ventilation produced a significant increase in perfusion pressure (+65%, P<0.001) and L‐NAME significantly increased this response further (+123%, P<0.01). After apamin, L‐NAME, indomethacin, post‐hypoxic basal pressure did not return to baseline values (P<0.001).
Glibenclamide partially inhibited the relaxant effects of isoprenaline (P<0.05) and salbutamol (P<0.001) but not that of SR 59104A. In contrast, charybdotoxin and apamin partially inhibited the relaxant effects of SR 59104A (P=0.053 and <0.01, respectively) but did not modify the effects of isoprenaline and salbutamol. L‐NAME partially inhibited the dilator response of salbutamol (P<0.01) and SR 59104A (P<0.05) but not that of isoprenaline.
We conclude that (a) EDRF exerts a significant inhibition of the hypoxic pulmonary response, (b) SKCa channel activation, EDRF and prostaglandins contribute to the reversal of the hypoxic pressure response, (c) the vasodilation induced by isoprenaline is mediated in part by activation of KATP channels, that of salbutamol by activation of KATP channels and EDRF. In contrast, SR 59104A partly operates through BKCa, SKCa channels and EDRF activation, differing in this from the β1 and β2‐adrenoceptor agonists.
The aims of this study were to compare, in the rat isolated perfused lung preparation, the antagonist effects of a nonselective β‐adrenoceptor agonist (isoprenaline), a selective β2‐adrenoceptor agonist (salbutamol) and a selective β3‐adrenoceptor agonist (SR 59104A) on the hypoxic pulmonary pressure response, and to investigate the role of K+ channels, endothelium derived relaxing factor and prostaglandins in these effects. K+ channels were inhibited by glibenclamide, charybdotoxin or apamin, NO synthase and cyclo‐oxygenase were inhibited by NG‐nitro‐L‐arginine methyl ester (L‐NAME) and indomethacin, respectively.
Hypoxic ventilation produced a significant increase in perfusion pressure (+65%, P<0.001) and L‐NAME significantly increased this response further (+123%, P<0.01). After apamin, L‐NAME, indomethacin, post‐hypoxic basal pressure did not return to baseline values (P<0.001).
Glibenclamide partially inhibited the relaxant effects of isoprenaline (P<0.05) and salbutamol (P<0.001) but not that of SR 59104A. In contrast, charybdotoxin and apamin partially inhibited the relaxant effects of SR 59104A (P=0.053 and <0.01, respectively) but did not modify the effects of isoprenaline and salbutamol. L‐NAME partially inhibited the dilator response of salbutamol (P<0.01) and SR 59104A (P<0.05) but not that of isoprenaline.
We conclude that (a) EDRF exerts a significant inhibition of the hypoxic pulmonary response, (b) SKCa channel activation, EDRF and prostaglandins contribute to the reversal of the hypoxic pressure response, (c) the vasodilation induced by isoprenaline is mediated in part by activation of KATP channels, that of salbutamol by activation of KATP channels and EDRF. In contrast, SR 59104A partly operates through BKCa, SKCa channels and EDRF activation, differing in this from the β1 and β2‐adrenoceptor agonists.
British Journal of Pharmacology (1999) 127, 421–428; doi:10.1038/sj.bjp.0702575
DOI: 10.1038/sj.bjp.0702575
View this article